Genius Group Spurs Stock Buyback, Shares Rocket
Genius Group Limited (NYSE: GNS) shares gained sharply Thursday. The Singapore-based AI-powered, Bitcoin-first education group announced that further to receiving shareholder and board approval for a share buyback of up to 20% of the company’s issued ordinary shares, on Wednesday, the company bought back one million shares of its stock on the open market at an average price of $1.30 per share.At Genius Group’s Annual General Meeting last Monday, shareholders voted 98.8% in favor of a proposed share buyback mandate which authorizes the Board to buy back up to 20% of the Company’s issued ordinary shares at any time over the next 12 months or until the company’s next AGM.Further to the shareholder approval, on July 8, 2025, the Company’s Board passed a resolution authorizing the CEO to execute the share buyback for up to 100% of the total shareholder approved buyback limit of up to 20% of the Company’s issued Class A Ordinary Shares, in such manner, proportion and timing as he deems most appropriate to preserve shareholder value.On Wednesday, CEO Roger Hamilton, executed a buyback of one million shares of the company’s ordinary shares at an average price of $1.30 per share.GNS shares began trading Thursday up 21 cents, or 15%, to $1.61.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


